SK287086B6 - 2H-1-Benzopyránové deriváty, farmaceutické prostriedky s ich obsahom a ich použitie - Google Patents
2H-1-Benzopyránové deriváty, farmaceutické prostriedky s ich obsahom a ich použitie Download PDFInfo
- Publication number
- SK287086B6 SK287086B6 SK939-2003A SK9392003A SK287086B6 SK 287086 B6 SK287086 B6 SK 287086B6 SK 9392003 A SK9392003 A SK 9392003A SK 287086 B6 SK287086 B6 SK 287086B6
- Authority
- SK
- Slovakia
- Prior art keywords
- alkyl
- phenyl
- compound
- benzopyran
- solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01101521A EP1229036B1 (en) | 2001-01-24 | 2001-01-24 | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| EP01118682A EP1281710A1 (en) | 2001-08-03 | 2001-08-03 | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| PCT/EP2002/000567 WO2002059113A1 (en) | 2001-01-24 | 2002-01-21 | 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK9392003A3 SK9392003A3 (en) | 2003-12-02 |
| SK287086B6 true SK287086B6 (sk) | 2009-11-05 |
Family
ID=26076450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK939-2003A SK287086B6 (sk) | 2001-01-24 | 2002-01-21 | 2H-1-Benzopyránové deriváty, farmaceutické prostriedky s ich obsahom a ich použitie |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6951883B2 (ru) |
| EP (1) | EP1355906B1 (ru) |
| JP (1) | JP4332349B2 (ru) |
| CN (1) | CN1261431C (ru) |
| AT (1) | ATE286894T1 (ru) |
| AU (1) | AU2002237282B2 (ru) |
| BR (1) | BR0207066A (ru) |
| CA (1) | CA2435775A1 (ru) |
| CZ (1) | CZ20032014A3 (ru) |
| DE (1) | DE60202590T2 (ru) |
| DK (1) | DK1355906T3 (ru) |
| DZ (1) | DZ3459A1 (ru) |
| EA (1) | EA006158B1 (ru) |
| ES (1) | ES2236485T3 (ru) |
| HK (1) | HK1060558A1 (ru) |
| HU (1) | HUP0401018A3 (ru) |
| IL (2) | IL157065A0 (ru) |
| MA (1) | MA26982A1 (ru) |
| MX (1) | MXPA03006505A (ru) |
| NO (1) | NO327808B1 (ru) |
| NZ (1) | NZ527144A (ru) |
| PL (1) | PL365062A1 (ru) |
| PT (1) | PT1355906E (ru) |
| SI (1) | SI1355906T1 (ru) |
| SK (1) | SK287086B6 (ru) |
| TN (1) | TNSN03043A1 (ru) |
| WO (1) | WO2002059113A1 (ru) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| CN101056868B (zh) | 2004-09-21 | 2012-05-02 | 马休爱德华兹股份有限公司 | 取代的苯并二氢吡喃衍生物、药物及其在治疗中的应用 |
| ES2377073T3 (es) * | 2004-09-21 | 2012-03-22 | Marshall Edwards, Inc. | Derivados de cromano sustituidos, medicamentos y utilización en terapia |
| WO2006032086A1 (en) * | 2004-09-21 | 2006-03-30 | Novogen Research Pty Ltd | Chroman derivatives, medicaments and use in therapy |
| JP4976649B2 (ja) * | 2004-09-21 | 2012-07-18 | マーシャル エドワーズ，インク． | 化合物 |
| AU2005201855B2 (en) * | 2004-09-21 | 2012-03-29 | Marshall Edwards, Inc. | Chroman derived compounds and formulations thereof for use in therapy |
| CN101444499B (zh) * | 2007-11-26 | 2012-12-05 | 湘北威尔曼制药股份有限公司 | 一种化合物及其组合物的新用途 |
| CA2816319C (en) | 2010-11-01 | 2020-06-30 | Marshall Edwards, Inc. | Isoflavonoid compounds and methods for the treatment of cancer |
| EP3010501B1 (en) | 2013-06-19 | 2021-11-03 | Seragon Pharmaceuticals, Inc. | Estrogen receptor modulator and uses thereof |
| HUE054998T2 (hu) | 2015-02-02 | 2021-10-28 | Mei Pharma Inc | Kombinációs terápiák emlõrák kezelésében való alkalmazásra |
| JP6946430B2 (ja) * | 2016-11-17 | 2021-10-06 | サノフイＳａｎｏｆｉ | 新規の置換ｎ−（３−フルオロプロピル）−ピロリジン化合物、それを製造するための方法、およびその治療的使用 |
| US20200215025A1 (en) * | 2017-09-15 | 2020-07-09 | Norbio No. 1 Pty Ltd | Treatment of excitotoxicity |
| CN112225716A (zh) * | 2020-10-30 | 2021-01-15 | 陕西嘉禾生物科技股份有限公司 | 一种鹰嘴豆牙素a的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3374245A (en) * | 1964-04-01 | 1968-03-19 | Ciba Geigy Corp | Unsaturated oxacycles |
| DE1518002C3 (de) * | 1965-01-02 | 1975-01-23 | Merck Patent Gmbh, 6100 Darmstadt | Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel |
| US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
| WO1998018774A1 (en) | 1996-10-28 | 1998-05-07 | Novo Nordisk A/S | Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| US5985306A (en) * | 1996-10-28 | 1999-11-16 | Novo Nordisk A/S | (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes |
| EP0944613B1 (en) * | 1996-12-13 | 2002-10-09 | Chugai Seiyaku Kabushiki Kaisha | Benzopyran derivatives |
| KR20000001793A (ko) | 1998-06-13 | 2000-01-15 | 이경하 | 신규한 벤조피란 또는 티오벤조피란 유도체 |
| JP2002533456A (ja) | 1998-12-30 | 2002-10-08 | シグナル ファーマシューティカルズ， インコーポレイテッド | エストロゲン受容体のモジュレートを行うための化合物および方法 |
-
2002
- 2002-01-21 SK SK939-2003A patent/SK287086B6/sk not_active IP Right Cessation
- 2002-01-21 PT PT02703564T patent/PT1355906E/pt unknown
- 2002-01-21 US US10/466,118 patent/US6951883B2/en not_active Expired - Fee Related
- 2002-01-21 IL IL15706502A patent/IL157065A0/xx unknown
- 2002-01-21 SI SI200230096T patent/SI1355906T1/xx unknown
- 2002-01-21 MX MXPA03006505A patent/MXPA03006505A/es active IP Right Grant
- 2002-01-21 JP JP2002559415A patent/JP4332349B2/ja not_active Expired - Fee Related
- 2002-01-21 CA CA002435775A patent/CA2435775A1/en not_active Abandoned
- 2002-01-21 CZ CZ20032014A patent/CZ20032014A3/cs unknown
- 2002-01-21 CN CNB02804066XA patent/CN1261431C/zh not_active Expired - Fee Related
- 2002-01-21 HU HU0401018A patent/HUP0401018A3/hu unknown
- 2002-01-21 DE DE60202590T patent/DE60202590T2/de not_active Expired - Lifetime
- 2002-01-21 NZ NZ527144A patent/NZ527144A/en unknown
- 2002-01-21 EA EA200300727A patent/EA006158B1/ru not_active IP Right Cessation
- 2002-01-21 BR BR0207066-9A patent/BR0207066A/pt not_active IP Right Cessation
- 2002-01-21 DK DK02703564T patent/DK1355906T3/da active
- 2002-01-21 AT AT02703564T patent/ATE286894T1/de not_active IP Right Cessation
- 2002-01-21 DZ DZ023459A patent/DZ3459A1/fr active
- 2002-01-21 AU AU2002237282A patent/AU2002237282B2/en not_active Ceased
- 2002-01-21 ES ES02703564T patent/ES2236485T3/es not_active Expired - Lifetime
- 2002-01-21 WO PCT/EP2002/000567 patent/WO2002059113A1/en active IP Right Grant
- 2002-01-21 EP EP02703564A patent/EP1355906B1/en not_active Expired - Lifetime
- 2002-01-21 PL PL02365062A patent/PL365062A1/xx not_active IP Right Cessation
-
2003
- 2003-07-08 TN TNPCT/EP2002/000567A patent/TNSN03043A1/en unknown
- 2003-07-15 MA MA27236A patent/MA26982A1/fr unknown
- 2003-07-23 NO NO20033318A patent/NO327808B1/no not_active IP Right Cessation
- 2003-07-23 IL IL157065A patent/IL157065A/en not_active IP Right Cessation
-
2004
- 2004-04-26 HK HK04102904A patent/HK1060558A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6964973B2 (en) | Bicyclic androgen and progesterone receptor modulator compounds and methods | |
| US5646149A (en) | Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents | |
| EP1246814B1 (en) | Compounds and methods for modulation of estrogen receptors | |
| EP1140889B1 (en) | Compounds and methods for modulation of estrogen receptors | |
| SK287086B6 (sk) | 2H-1-Benzopyránové deriváty, farmaceutické prostriedky s ich obsahom a ich použitie | |
| SK2862000A3 (en) | Substituted chroman derivatives | |
| AU2002237282A1 (en) | 2H-1-Benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof | |
| JPH07188207A (ja) | １−［２ｈ−１−ベンゾピラン−２−オン−８−イル］−ピペラジン誘導体 | |
| EP1229036A1 (en) | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof | |
| Gauthier et al. | Synthesis and structure–activity relationships of analogs of EM-652 (acolbifene), a pure selective estrogen receptor modulator. Study of nitrogen substitution | |
| US20050282863A1 (en) | Novel-N substituted dihydrobenzothiepino, dihydrobenzoxepino and tetrahydro benzocyclohepta indoles as selective estrogen receptor modulators | |
| AU2746902A (en) | New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them | |
| EP1281710A1 (en) | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof | |
| SK20795A3 (en) | 1-/2-(1h-indene-3-yl) ethyl/-4-(naphthyl) piperazine derivatives, method of their preparation and pharmaceutical compositions containing these derivatives | |
| AU697050C (en) | Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents | |
| CZ2000948A3 (cs) | Substituované chromanové deriváty |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20090918 |